US HB4418 | 2021-2022 | 117th Congress
Status
Sponsorship: Partisan Bill (Democrat 8)
Status: Introduced on July 13 2021 - 25% progression, died in committee
Action: 2021-07-13 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on July 13 2021 - 25% progression, died in committee
Action: 2021-07-13 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Summary
To amend title XI of the Social Security Act to provide for drug manufacturer price transparency.
Title
SPIKE Act Stopping the Pharmaceutical Industry from Keeping drugs Expensive Act
Sponsors
| Rep. Steven Horsford [D-NV] | Rep. Jamie Raskin [D-MD] | Rep. Abigail Spanberger [D-VA] | Rep. Eleanor Norton [D-DC] |
| Sen. Elissa Slotkin [D-MI] | Rep. Chrissy Houlahan [D-PA] | Rep. David Cicilline [D-RI] | Rep. Joseph Neguse [D-CO] |
History
| Date | Chamber | Action |
|---|---|---|
| 2021-07-13 | House | Referred to the Subcommittee on Health. |
| 2021-07-13 | House | Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. |
| 2021-07-13 | House | Introduced in House |
Subjects
US Congress State Sources
| Type | Source |
|---|---|
| Summary | https://www.congress.gov/bill/117th-congress/house-bill/4418/all-info |
| Text | https://www.congress.gov/117/bills/hr4418/BILLS-117hr4418ih.pdf |
